These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6542412)

  • 1. [Plasma levels of gitoxin (by RIA and rubidium-86 uptake) and systolic time after treatment with a single dose of gitoformate].
    Dei Cas L; Affatato A; Buia E; Casciarri G; Faggiano P; Giunti G; Metra M; Pelagatti T; Quinzanini M
    Cardiologia; 1984; 29(5-6):291-300. PubMed ID: 6542412
    [No Abstract]   [Full Text] [Related]  

  • 2. Extraordinary efficacy of 16 alpha-gitoxin, an ultra-short acting semi-synthetic digitalis glycoside.
    Haustein KO; Bauer R
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):299-304. PubMed ID: 7921531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in 86-rubidium uptake in erythrocytes of digoxin-treated patients, in heart failure with sinus rhythm. Relationship to clinical effects.
    Zannad F; Royer RJ; Robert J
    Eur J Cardiol; 1981; 12(5):275-84. PubMed ID: 6265219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum digoxin estimation in adults by a non-RIA method (an 86Rb uptake inhibition study).
    Khanna CM; Jaggi CB; George S; Yadav HS
    J Assoc Physicians India; 1983 Dec; 31(12):767-9. PubMed ID: 6674301
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-dependent shortening of systolic time intervals after intake of pengitoxin.
    Haustein KO; Hentschel H
    Int J Clin Pharmacol Res; 1987; 7(1):19-25. PubMed ID: 3583485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma levels of cardiac glycosides and the electrocardiogram during moderately rapid and slow digitalization with beta-methyl-digoxin in normal volunteers (author's transl)].
    Belz GG; Rudofsky G; Belz G
    Dtsch Med Wochenschr; 1974 Feb; 99(8):329-32. PubMed ID: 4822437
    [No Abstract]   [Full Text] [Related]  

  • 7. Elimination of 16-acetyl-gitoxin in patients suffering from impaired liver function.
    Haustein KO; Sensing H; Wesser M
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):379-81. PubMed ID: 3623742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum levels and kinetics of digoxin in patients with hyperthyroidism (author's transl)].
    Gaita F; Bocchiardo M; Brossa C; Molinatti GM; Rosettani E; Brusca A
    G Ital Cardiol; 1980; 10(7):836-42. PubMed ID: 7461331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between verapamil and beta-methyldigoxin. Study by 86Rubidium uptake in erythrocytes.
    De Cesaris R; Balestrazzi M; Chiarappa R; Ranieri G
    Int J Clin Pharmacol Res; 1983; 3(2):107-9. PubMed ID: 6679512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies between serum glycoside concentration and systolic time intervals in healthy subjects following administration of beta-methyldigoxin].
    Haasis R; Larbig D; Burck HC
    Verh Dtsch Ges Inn Med; 1975; 81():1664-6. PubMed ID: 1227051
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum glycoside levels by rubidium assay.
    Ritzmann LW; Bangs CC; Coiner D; Custis JM; Walsh JR
    Arch Intern Med; 1973 Dec; 132(6):823-30. PubMed ID: 4757255
    [No Abstract]   [Full Text] [Related]  

  • 12. Half-life plasma following repetitive application of beta-acetyl digoxin in man.
    Belz GG; Nübling H
    Klin Wochenschr; 1975 Jun; 53(11):543-4. PubMed ID: 1152346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plasma digoxin concentration, red cell rubidium 86 uptake and control of ventricular rate in patients being digitalized for artrial fibrilation.
    Hibble AG; Grahame-Smith DG
    Clin Sci; 1972 Jan; 42(1):3P. PubMed ID: 5008538
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of renal insufficiency on the pharmacokinetic parameters of gitoformate in man].
    Carlier J; de Landsheere C; Lesne M; Muisers A
    Therapie; 1979; 34(2):255-8. PubMed ID: 494149
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the pharmacokinetic parameters of digoxin and SC4453 a digoxin analogue, following a single bolus i.v. dose and following an infusion preceeded by an i.v. loading dose in the guinea-pig.
    Randimbivololona F; Lesne M
    J Pharmacol; 1983; 14(1):9-17. PubMed ID: 6834854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma kinetics of digoxin in the cat.
    Bolton GR; Powell W
    Am J Vet Res; 1982 Nov; 43(11):1994-9. PubMed ID: 7181198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic evaluation of the pharmacodynamic effect of digoxin, following the administration of a single intravenous dose to healthy volunteers].
    Leucuţa SE; Blaga S; Vlaicu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(2):141-50. PubMed ID: 2888173
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative clinical characteristics of methods of digoxin microanalysis].
    Trusov VV; Zelenin AA; Dundua MG
    Med Radiol (Mosk); 1984 Nov; 29(11):21-3. PubMed ID: 6390066
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of the plasma digoxin level].
    Kruyswijk HH; Jambroes G; Willebrands AF; Maas AH; Dunning AJ
    Ned Tijdschr Geneeskd; 1973 Dec; 117(48):1797-802. PubMed ID: 4274795
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of age on the pharmacokinetic parameters of digoxin].
    Korkushko OV; Orlov PA; Bezverkhaia IS; Belyĭ AA
    Farmakol Toksikol; 1984; 47(3):101-4. PubMed ID: 6734802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.